Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2007 Filed Apr 4, 2007 21:24 UTC |
BODINE CHRIS WExecutive Vice President
|
GrantStock Option · Derivative | 136,089 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000080 · doc.xml · derivative · entry 16 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,089 Underlying: Common Stock · 136,089 shares Expires 2014-04-02 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:24 UTC |
BODINE CHRIS WExecutive Vice President
|
GrantCommon Stock (Restricted) | 13,174 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000080 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,388 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:25 UTC |
Spalding William REVP Caremark Pharmacy Services
|
GrantStock Option · Derivative | 208,750 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000083 · doc.xml · derivative · entry 3 Spalding William R · CIK 0001331844 · EVP Caremark Pharmacy Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,750 Underlying: Common Stock · 208,750 shares Expires 2014-04-02 F2 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:25 UTC |
FERDINANDI V MICHAELSenior Vice President
|
GrantStock Option · Derivative | 60,484 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000081 · doc.xml · derivative · entry 18 FERDINANDI V MICHAEL · CIK 0001194412 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,484 Underlying: Common Stock · 60,484 shares Expires 2014-04-02 F7 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:25 UTC |
FERDINANDI V MICHAELSenior Vice President
|
GrantCommon Stock (Restricted) | 5,855 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000081 · doc.xml · nonDerivative · entry 3 FERDINANDI V MICHAEL · CIK 0001194412 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,681 F3 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:26 UTC |
MCLURE HOWARD APresident, Caremark Pharm Serv
|
GrantStock Option · Derivative | 208,750 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000084 · doc.xml · derivative · entry 8 MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,750 Underlying: Common Stock · 208,750 shares Expires 2014-04-02 F2 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:25 UTC |
Price Paula AController
|
GrantStock Option · Derivative | 26,462 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000082 · doc.xml · derivative · entry 4 Price Paula A · CIK 0001369240 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,462 Underlying: Common Stock · 26,462 shares Expires 2014-04-02 F2 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:25 UTC |
Price Paula AController
|
GrantCommon Stock (Restricted) | 2,562 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000082 · doc.xml · nonDerivative · entry 2 Price Paula A · CIK 0001369240 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,499 F1 · shares: Consist of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 100% on 4/2/2011. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:31 UTC |
RICKARD DAVID BChief Financial Officer
|
GrantStock Option · Derivative | 136,089 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000085 · doc.xml · derivative · entry 15 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,089 Underlying: Common Stock · 136,089 shares Expires 2014-04-02 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:31 UTC |
RICKARD DAVID BChief Financial Officer
|
GrantCommon Stock (Restricted) | 13,174 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000085 · doc.xml · nonDerivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,659 F2 · shares: Consist of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 100% on 12/20/2010. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:18 UTC Amendment |
RYAN THOMAS MDirector · CEO & President
|
GrantCommon Stock (Restricted) | 116,212 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000086 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974,389 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:19 UTC Amendment |
RICKARD DAVID BChief Financial Officer
|
GrantCommon Stock (Restricted) | 13,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000088 · doc.xml · nonDerivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,559 F2 · shares: Consist of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 100% on 12/20/2010. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:19 UTC Amendment |
SGARRO DOUGLAS AExecutive Vice President
|
GrantCommon Stock (Restricted) | 13,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000087 · doc.xml · nonDerivative · entry 2 SGARRO DOUGLAS A · CIK 0001194417 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,391 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/22/2014. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:19 UTC Amendment |
MERLO LARRY JExecutive Vice President
|
GrantCommon Stock | 13,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000089 · doc.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,267 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:20 UTC Amendment |
BODINE CHRIS WExecutive Vice President
|
GrantCommon Stock (Restricted) | 13,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000090 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,288 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:20 UTC Amendment |
FERDINANDI V MICHAELSenior Vice President
|
GrantCommon Stock (Restricted) | 5,811 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000091 · doc.xml · nonDerivative · entry 3 FERDINANDI V MICHAEL · CIK 0001194412 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,637 F3 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:20 UTC Amendment |
Price Paula AController
|
GrantCommon Stock (Restricted) | 2,543 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000092 · doc.xml · nonDerivative · entry 2 Price Paula A · CIK 0001369240 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,480 F1 · shares: Consist of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 100% on 4/2/2011. Read SEC document |
| March 28, 2007 Filed Mar 29, 2007 20:20 UTC |
DORMAN DAVID WDirector
|
GrantShare Credits · Derivative | 29 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000074 · doc.xml · derivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 Underlying: Common Stock · 29 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| March 28, 2007 Filed Mar 29, 2007 20:21 UTC |
ROSENBERG SHELI ZDirector
|
GrantCommon Stock | 29 | $33.95 | $984.55 |
DisclosureSEC source: 0000064803-07-000075 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,814 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 23, 2007 Filed Mar 26, 2007 20:51 UTC |
WILLIAMS KRISTEN GIBNEYDirector
|
GrantStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000070 · doc.xml · derivative · entry 6 WILLIAMS KRISTEN GIBNEY · CIK 0001197683 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BANKS EDWIN MDirector
|
GrantStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · derivative · entry 6 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,726 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BANKS EDWIN MDirector
|
GrantStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · derivative · entry 5 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BANKS EDWIN MDirector
|
GrantStock Option · Derivative | 46,856 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · derivative · entry 4 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,856 Underlying: Common Stock · 46,856 shares Expires 2014-01-02 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BANKS EDWIN MDirector
|
GrantStock Option · Derivative | 46,849 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · derivative · entry 3 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,849 Underlying: Common Stock · 46,849 shares Expires 2013-02-25 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BANKS EDWIN MDirector
|
GrantCommon Stock | 11,690 | $34.80 | $406,812.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · nonDerivative · entry 2 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,884 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BANKS EDWIN MDirector
|
GrantCommon Stock | 24,194 | $34.80 | $841,951.20 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · nonDerivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,194 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BROWN C DAVID IIDirector
|
GrantStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 8 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,726 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BROWN C DAVID IIDirector
|
GrantStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 7 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BROWN C DAVID IIDirector
|
GrantStock Option · Derivative | 46,856 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 6 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,856 Underlying: Common Stock · 46,856 shares Expires 2014-01-02 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BROWN C DAVID IIDirector
|
GrantStock Option · Derivative | 46,849 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 5 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,849 Underlying: Common Stock · 46,849 shares Expires 2013-02-25 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BROWN C DAVID IIDirector
|
GrantStock Option · Derivative | 46,844 | $0.00 Strike: $8.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 4 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,844 Underlying: Common Stock · 46,844 shares Expires 2012-01-02 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BROWN C DAVID IIDirector
|
GrantStock Option · Derivative | 46,846 | $0.00 Strike: $6.66 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 3 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,846 Underlying: Common Stock · 46,846 shares Expires 2011-03-20 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BROWN C DAVID IIDirector
|
GrantCommon Stock | 22,735 | $34.80 | $791,178.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · nonDerivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,085 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC |
BROWN C DAVID IIDirector
|
GrantCommon Stock | 8,350 | $34.80 | $290,580.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,350 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
GrantStock Option · Derivative | 843,164 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 7 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 843,164 Underlying: Common Stock · 843,392 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
GrantStock Option · Derivative | 1,405,799 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 6 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,405,799 Underlying: Common Stock · 1,405,799 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
GrantStock Option · Derivative | 1,124,153 | $0.00 Strike: $17.08 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 5 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,153 Underlying: Common Stock · 1,124,153 shares Expires 2014-05-10 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
GrantStock Option · Derivative | 3,017,937 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 4 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017,937 Underlying: Common Stock · 3,017,937 shares Expires 2011-08-28 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
GrantStock Option · Derivative | 3,794,611 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 3 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,794,611 Underlying: Common Stock · 3,794,611 shares Expires 2010-03-08 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
GrantStock Option · Derivative | 1,874 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 2 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,874 Underlying: Common Stock · 1,874 shares Expires 2008-09-21 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
GrantCommon Stock | 133,600 | $34.80 | $4,649,280.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,600 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
HEADRICK ROGER LDirector
|
GrantStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000063 · doc.xml · derivative · entry 6 HEADRICK ROGER L · CIK 0001192145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,726 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
HEADRICK ROGER LDirector
|
GrantStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000063 · doc.xml · derivative · entry 5 HEADRICK ROGER L · CIK 0001192145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
HEADRICK ROGER LDirector
|
GrantStock Option · Derivative | 46,844 | $0.00 Strike: $8.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000063 · doc.xml · derivative · entry 4 HEADRICK ROGER L · CIK 0001192145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,844 Underlying: Common Stock · 46,844 shares Expires 2012-01-02 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
HEADRICK ROGER LDirector
|
GrantStock Option · Derivative | 46,851 | $0.00 Strike: $6.53 | $0.00 |
DisclosureSEC source: 0000064803-07-000063 · doc.xml · derivative · entry 3 HEADRICK ROGER L · CIK 0001192145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,851 Underlying: Common Stock · 46,851 shares Expires 2011-01-12 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
HEADRICK ROGER LDirector
|
GrantCommon Stock | 29,313 | $34.80 | $1,020,092.40 |
DisclosureSEC source: 0000064803-07-000063 · doc.xml · nonDerivative · entry 2 HEADRICK ROGER L · CIK 0001192145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,961 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
HEADRICK ROGER LDirector
|
GrantCommon Stock | 282,648 | $34.80 | $9,836,150.40 |
DisclosureSEC source: 0000064803-07-000063 · doc.xml · nonDerivative · entry 1 HEADRICK ROGER L · CIK 0001192145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,648 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
JOYCE WILLIAM HDirector
|
GrantCommon Stock | 504 | $34.80 | $17,539.20 |
DisclosureSEC source: 0000064803-07-000064 · doc.xml · nonDerivative · entry 1 JOYCE WILLIAM H · CIK 0001009124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,390 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark shares owned by the reporting person to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
MCLURE HOWARD APresident, Caremark Pharm Serv
|
GrantStock Option · Derivative | 234,212 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000065 · doc.xml · derivative · entry 10 MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,212 Underlying: Common Stock · 234,212 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC |
MCLURE HOWARD APresident, Caremark Pharm Serv
|
GrantStock Option · Derivative | 260,459 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000065 · doc.xml · derivative · entry 9 MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,459 Underlying: Common Stock · 260,459 shares Expires 2015-06-27 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.